Related Experiment Videos
Genetic and environmental factors in systemic sclerosis
1Department of Rheumatology, Scripps Clinic and Research Foundation, La Jolla, CA 92037.
Current Opinion in Rheumatology
|December 1, 1992
Summary
Systemic sclerosis involves immune dysregulation, with specific human leukocyte antigen (HLA) alleles linked to autoantibodies. Environmental factors and genetic predispositions suggest systemic sclerosis may encompass multiple distinct disorders.
Area of Science:
- Immunology
- Genetics
- Environmental Health
Background:
- Autoantibodies and immune dysregulation are implicated in systemic sclerosis.
- Genetic studies link human leukocyte antigen (HLA)-DQ alleles to anticentromere antibodies.
- Environmental factors like silica and occupational exposures are associated with systemic sclerosis-like conditions.
Purpose of the Study:
- To explore the role of immune dysregulation, genetic factors (HLA alleles), and environmental exposures in systemic sclerosis pathogenesis.
- To investigate the clinical value of determining HLA alleles for risk stratification.
- To examine the heterogeneity of systemic sclerosis, suggesting it may be a group of distinct disorders.
Main Methods:
- Review of genetic association studies focusing on major histocompatibility complex (MHC)-encoded antigens.
- Analysis of environmental factors linked to systemic sclerosis-like skin diseases.
- Evaluation of autoantibody profiles and clinical heterogeneity.
Main Results:
- Association found between particular HLA-DQ alleles and anticentromere antibodies.
- Various environmental factors identified as potential triggers or risk factors.
- Significant heterogeneity in clinical features, MHC status, and autoantibody profiles observed.
Conclusions:
- Determining MHC alleles may aid in identifying patients at risk for pulmonary fibrosis or severe skin disease.
- Systemic sclerosis heterogeneity suggests it may represent a spectrum of disorders with unique genetic and environmental risk factors.
- Further research is needed to clarify the precise roles of MHC antigens and autoantibodies in systemic sclerosis pathogenesis.